Erica Bickerton is a notable inventor based in Woking, GB. She has made significant contributions to the field of virology, particularly in the development of vaccines for infectious diseases. With a total of 4 patents to her name, her work is recognized for its potential impact on public health.

Latest Patents

Among her latest patents, Erica has developed a live, attenuated coronavirus that includes a mutation in non-structural protein nsp-3 and/or deletion of accessory proteins 3a and 3b. This invention may serve as a vaccine for treating and preventing diseases such as infectious bronchitis in subjects. Another significant patent involves a live, attenuated coronavirus featuring a variant replicase gene that encodes polyproteins with mutations in non-structural proteins nsp-10, nsp-14, nsp-15, or nsp-16. This innovation also aims to provide a vaccine for infectious bronchitis.

Career Highlights

Erica Bickerton is currently affiliated with The Pirbright Institute, where she continues her research and development efforts. Her work is characterized by a commitment to advancing vaccine technology and improving health outcomes.

Collaborations

Erica collaborates with esteemed colleagues such as Paul Britton and Sarah Keep, contributing to a dynamic research environment that fosters innovation and discovery.

Conclusion

Erica Bickerton's contributions to the field of virology and vaccine development are noteworthy. Her innovative patents and collaborative efforts at The Pirbright Institute highlight her dedication to improving public health through scientific research.

This text is generated by artificial intelligence and may not be accurate.